﻿<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article xml:lang="en" article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Korean J Physiol Pharmacol</journal-id>
<journal-title-group>
<journal-title>The Korean Journal of Physiology &#38; Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology</journal-title>
<abbrev-journal-title abbrev-type="publisher">Korean J. Physiol. Pharmacol.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="ppub">1226-4512</issn>
<issn pub-type="epub">2093-3827</issn>
<publisher>
<publisher-name>The Korean Physiological Society and The Korean Society of Pharmacology</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.4196/kjpp.2022.26.4.229</article-id>
<article-id pub-id-type="publisher-id">kjpp-26-4-229</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Glycine induces enhancement of bactericidal activity of neutrophils</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Kang</surname><given-names>Shin-Hae</given-names></name>
<xref rid="aff1" ref-type="aff">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Ham</surname><given-names>Hwa-Yong</given-names></name>
<xref rid="aff1" ref-type="aff">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Hong</surname><given-names>Chang-Won</given-names></name>
<xref rid="aff2" ref-type="aff">2</xref>
<xref rid="cor1" ref-type="corresp">*</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Song</surname><given-names>Dong-Keun</given-names></name>
<xref rid="aff1" ref-type="aff">1</xref>
<xref rid="cor1" ref-type="corresp">*</xref>
</contrib>
</contrib-group>
<aff id="aff1"><label>1</label>Department of Pharmacology, College of Medicine, Hallym University, Chuncheon 24252, <country>Korea</country></aff>
<aff id="aff2"><label>2</label>Department of Physiology, School of Medicine, Kyungpook National University, Daegu 41944, <country>Korea</country></aff>
<author-notes>
<corresp id="cor1"><label>*</label><bold>Correspondence</bold> Dong-Keun Song, E-mail: <email xlink:href="dksong@hallym.ac.kr">dksong@hallym.ac.kr</email>, Chang-Won Hong, E-mail: <email xlink:href="cwhong@knu.ac.kr">cwhong@knu.ac.kr</email></corresp>
<fn id="fn1" fn-type="con"><p><bold>Author contributions:</bold> D.-K.S. and C.-W.H. conceived and designed the experiments; C.-W.H., H.-Y.H. and S.-H.K. performed the experiments and analyzed the data; D.-K.S. and C.-W.H. wrote the paper.</p></fn>
</author-notes>
<pub-date pub-type="ppub">
<day>30</day>
<month>6</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="epub">
<day>30</day>
<month>6</month>
<year>2022</year>
</pub-date>
<volume>26</volume>
<issue>4</issue>
<fpage>229</fpage>
<lpage>238</lpage>
<history>
<date date-type="received">
<day>24</day>
<month>11</month>
<year>2021</year>
</date>
<date date-type="rev-recd">
<day>30</day>
<month>3</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>13</day>
<month>4</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#169; Korean J Physiol Pharmacol</copyright-statement>
<copyright-year>2022</copyright-year>
<license license-type="open-access">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0">http://creativecommons.org/licenses/by-nc/4.0</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<abstract>
<p>Severe bacterial infections are frequently accompanied by depressed neutrophil functions. Thus, agents that increase the microbicidal activity of neutrophils could add to a direct antimicrobial therapy. Lysophosphatidylcholine augments neutrophil bactericidal activity <italic>via</italic> the glycine (Gly)/glycine receptor (GlyR) &#945;2/TRPM2/p38 mitogen-activated protein kinase (MAPK) pathway. However, the direct effect of glycine on neutrophil bactericidal activity was not reported. In this study, the effect of glycine on neutrophil bactericidal activity was examined. Glycine augmented bactericidal activity of human neutrophils (EC<sub>50</sub> = 238 &#956;M) in a strychnine (a GlyR antagonist)-sensitive manner. Glycine augmented bacterial clearance in mice, which was also blocked by strychnine (0.4 mg/kg, s.c.). Glycine enhanced NADPH oxidase-mediated reactive oxygen species (ROS) production and TRPM2-mediated [Ca<sup>2+</sup>]<sub>i</sub> increase in neutrophils that had taken up <italic>E. coli</italic>. Glycine augmented Lucifer yellow uptake (fluid-phase pinocytosis) and azurophil granule-phagosome fusion in neutrophils that had taken up <italic>E. coli</italic> in an SB203580 (a p38 MAPK inhibitor)-sensitive manner. These findings indicate that glycine augments neutrophil microbicidal activity by enhancing azurophil granule-phagosome fusion <italic>via</italic> the GlyR&#945;2/ROS/calcium/p38 MAPK pathway. We suggest that glycine could be a useful agent for increasing neutrophil bacterial clearance.</p>
</abstract>
<kwd-group>
<kwd>Calcium</kwd>
<kwd>Glycine</kwd>
<kwd>Neutrophil</kwd>
<kwd>p38 MAPK</kwd>
<kwd>Reactive oxygen species</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec sec-type="intro">
<title>INTRODUCTION</title>
<p>Neutrophils play a pivotal role in bacterial infections as a first line of defense against invading microbes [<xref rid="ref1" ref-type="bibr">1</xref>,<xref rid="ref2" ref-type="bibr">2</xref>], However, key neutrophil functions regarding microbial clearance (chemotaxis, phagocytosis, respiratory burst, and intracellular killing of bacteria) are frequently compromised in severe bacterial infections [<xref rid="ref3" ref-type="bibr">3</xref><xref rid="ref4" ref-type="bibr"/><xref rid="ref5" ref-type="bibr"/><xref rid="ref6" ref-type="bibr"/><xref rid="ref7" ref-type="bibr"/><xref rid="ref8" ref-type="bibr"/><xref rid="ref9" ref-type="bibr"/>-<xref rid="ref10" ref-type="bibr">10</xref>]. Further, among the patients with bacterial infections, those exhibiting reduced intracellular killing of bacteria by neutrophils display higher infection-related mortality [<xref rid="ref4" ref-type="bibr">4</xref>]. Meanwhile, impaired intracellular killing of <italic>Staphylococcus aureus</italic> (<italic>S. aureus</italic>) by neutrophils precedes nosocomial infections in critically ill patients [<xref rid="ref11" ref-type="bibr">11</xref>]. In all of these circumstances where intracellular killing of bacteria by neutrophils is depressed, substances that enhance neutrophil functions could be helpful as an adjunctive immunomodulatory therapy [<xref rid="ref12" ref-type="bibr">12</xref>].</p>
<p>Previously we reported that lysophosphatidylcholine (LPC), an endogenous lipid, enhances neutrophil bactericidal activity <italic>via</italic> the glycine (Gly)/glycine receptor (GlyR) &#945;2/TRPM2/p38 mitogen-activated protein kinase (MAPK) pathway [<xref rid="ref13" ref-type="bibr">13</xref>]. LPC <italic>via</italic> G2A (from G2 accumulation, also known as the G protein-coupled receptor GPCR132) induces the translocation of intracellularly located GlyR&#945;2 to the plasma membrane [<xref rid="ref14" ref-type="bibr">14</xref>]. Extracellular glycine is necessary for LPC-induced enhancement of neutrophil bactericidal activity and LPC-induced p38 MAPK activation [<xref rid="ref13" ref-type="bibr">13</xref>].</p>
<p>However, the effect of glycine <italic>per se</italic> (in the absence of LPC) on neutrophil bactericidal activity is unknown. In this study, we show that glycine enhances neutrophil bactericidal activity by enhancing azurophil granule-phagosome fusion <italic>via</italic> the GlyR&#945;2/reactive oxygen species (ROS)/calcium/p38 MAPK pathway, proposing glycine as a useful antimicrobial agent that enhances neutrophil bactericidal activity.</p>
</sec>
<sec sec-type="methods">
<title>METHODS</title>
<sec>
<title>Preparation of neutrophils</title>
<p>Venous blood was taken from healthy volunteers in accordance with a protocol approved by Ethnic committee of Hallym University. Neutrophils were purified from heparinized venous blood from healthy volunteer donors. In brief, neutrophils were isolated by density centrifugation in Histopaque-1077 followed by dextran sedimentation. Residual erythrocytes were eliminated with hypotonic lysis. The purity of neutrophils counted by Diff Quik staining was &#62; 95% on average. The viability of neutrophils stained with trypan blue was &#62; 99%. After the isolation procedure, neutrophils were dispersed in RPMI 1640 supplemented with 5% fetal bovine serum (FBS).</p>
</sec><sec>
<title>Assay of intracellular killing of <italic>E. coli</italic> by human neutrophils</title>
<p>Bactericidal activity of human neutrophils was measured by a slightly modified version of a previously described method [<xref rid="ref13" ref-type="bibr">13</xref>,<xref rid="ref14" ref-type="bibr">14</xref>]. In brief, neutrophils (4 &#215; 10<sup>6</sup>/ml, 0.5 ml) were seeded on a 13-mm plastic coverslip (coated overnight with 0.05% poly-L-lysine) in a 24-well plate for 1 h in a humidified CO<sub>2</sub> incubator (5% CO<sub>2</sub> and 95% air atmosphere). Coverslips were then transferred to a 60-mm dish (6 coverslips/dish) containing 2 &#215; 10<sup>7</sup> <italic>E. coli</italic> (overnight-cultured <italic>E. coli</italic> [DH5-&#945;] was opsonized with 10% human serum for 30 min) at a neutrophil/<italic>E. coli</italic> ratio of 1:10 for 20 min for <italic>E. coli</italic> uptake. After the 20 min uptake, 18.3 &#177; 1.9% (mean &#177; standard error [SE], n = 2) of <italic>E. coli</italic> was removed by adherent neutrophils. Coverslips were then transferred to a 24-well plate with 500 &#956;l of RPMI-1640 (supplemented with 5% FBS) containing vehicle or glycine (133, 300, 500, and 1,000 &#956;M). After 15 min, the coverslips were transferred to a 24-well plate with ice-cold distilled water for 1 h for lysis of neutrophils (colony forming units [CFUs] after 15 min of incubation). To evaluate the total number of phagocytosed <italic>E. coli</italic>, some coverslips were directly transferred to ice-cold distilled water after 20 min of <italic>E. coli</italic> uptake without an additional 15 min of incubation with glycine (CFUs before 15 min of incubation). <italic>E. coli</italic> was plated in lysogeny broth agar plate and cultured overnight at 37&#176;C, after which viable colonies were counted. The percentage of bacteria killed was calculated as 100&#215; (1-CFUs after 15 min of incubation/CFUs before 15 min of incubation). To determine the effects of various inhibitors, assay of bactericidal activity was performed in the presence of strychnine (1 &#956;M), diphenylene iodonium (DPI) (1 &#956;M), protease inhibitor mixture (leupeptin [10 &#956;g/ml], <italic>N</italic>-tosyl-L-leucin chloromethyl ketone [10 &#956;g/ml], pepstatin A [10 &#956;g/ml], aprotinin [10 &#956;g/ml], and phenylmethylsulfonyl fluoride [1 mM]) or SB203580 (10 &#956;M). All media were supplemented with 5% FBS.</p>
</sec><sec>
<title>Clearance of intraperitoneally injected <italic>E. coli</italic></title>
<p>Male ICR mice at the age of 6 weeks (25&#8211;28 g body weight) were used. Procedures for the animal experiments were approved by the Animal Experimentation Committee at Hallym University. Mice were intraperitoneally injected with <italic>E. coli</italic> (5 &#215; 10<sup>8</sup>). Mice were pretreated subcutaneously with PBS or strychnine (0.4 mg/kg) for 30 min before <italic>E. coli</italic> injection. At 30 min after <italic>E. coli</italic> injection, vehicle (PBS) or glycine (30 mg/kg) was subcutaneously injected. Eight hours after <italic>E.</italic> <italic>coli</italic> injection, mice were sacrificed, and peritoneal lavage fluid was collected and cultured overnight on blood agar base plates (Trypticase Soy Agar Deeps; BD, Franklin Lakes, NJ, USA) at 37&#176;C and the numbers of CFUs were counted.</p>
</sec><sec>
<title>Measurement of <sup>36</sup>CI<sup>&#8211;</sup> Uptake</title>
<p>Measurement of <sup>36</sup>CI<sup>&#8211;</sup> uptake was performed in accordance with a previously described method [<xref rid="ref15" ref-type="bibr">15</xref>]. Briefly, 6 &#215; 10<sup>6</sup>/ml neutrophils were incubated in HEPES buffer at 37&#176;C for 1 h (in mM: 20 HEPES, 118 NaCl, 4.7 KCl, 1.2 MgSO<sub>4</sub> and 2.5 CaCl<sub>2</sub>, pH 7.4). Neutrophils pretreated with phorbol myristate acetate (PMA) (2 &#956;g/ml) for 15 min were exposed to 2 &#956;Ci/ml <sup>36</sup>CI<sup>&#8211;</sup> in the presence or absence of glycine (1 mM) for 10 s and transferred to a Wheaton 25 mm vacuum filter system. <sup>36</sup>CI<sup>&#8211;</sup> uptake was terminated by washing twice with ice-cold HEPES buffer through 25 mm glass microfiber filters (Whatman GF/A; Cytiva, Marlborough, MA, USA). Glass fiber filters were placed in scintillation vials, and proteins were solubilized with 1.6 ml of 1 N NaOH for 1 h. EcoLume (8 ml) was added and radioactivity was measured using a liquid scintillation detector (LS-3801; Beckman, Fullerton, CA, USA). In some experiments, neutrophils were pretreated for 30&#8211;60 min with strychnine (1 &#956;M) before exposure to 2 &#956;Ci/ml <sup>36</sup>CI<sup>&#8211;</sup> in the presence of glycine (1 mM) for 10 s.</p>
</sec><sec>
<title>Nitrogen cavitation</title>
<p>Purified neutrophils were resuspended in ice-cold relaxation buffer (minus EGTA, 100 mM KCl, 3 mM NaCl, 1 mM ATP[N]<sub>2</sub>, 3.5 mM MgCl<sub>2</sub>, 10 mM piperazine N, N&#8217;-bis(2-ethansulfonic acid), pH 7.3) and pressurized with N<sub>2</sub> for 20 min at 350 psi with constant stirring in a nitrogen bomb (Parr Instrument Company, Moline, IL, USA) at 4&#176;C. Cavitates were admixed with EGTA, pH 7.4, sufficient for a final concentration of 1.25 mM and centrifuged for 15 min at 500 g to remove nuclei and unbroken cells. Samples were kept on ice until fractionation.</p>
</sec><sec>
<title>Subcellular fractionation</title>
<p>Nuclei and unbroken cells were pelleted, and the supernatant was obtained by centrifugation of the cavitate at 500 g for 15 min at 4&#176;C. A density gradient of 9 ml of Percoll was prepared (1.120 g/ml, 1.090 g/ml, and 1.050 g/ml). The supernatant, cavitated neutrophils, was loaded onto three separate Percoll density gradients and centrifuged at 48,000 <italic>g</italic> for 20 min in a P28S rotor in a Himac CP80MX centrifuge (Hitachi, Tokyo, Japan). After Percoll density gradient centrifugation, four distinct bands were observed from the bottom designated the &#945;-band (azurophil granules), the &#946;<sub>1</sub>-band (specific granules), the &#946;<sub>2</sub>-band (gelatinase granules), and the &#947;-band (secretory vesicles and plasma membranes). Each fraction was collected and ultracentrifuged at 35,000 rpm for 120 min to remove the Percoll. After centrifugation, the granule layer was visible as a disk form above the Percoll pellet.</p>
</sec><sec>
<title>Flow cytometry</title>
<p>To analyze the surface expression of GlyR&#945;2, neutrophils (3 &#215; 10<sup>6</sup>/ml) were stimulated with <italic>E. coli</italic> for 5 min in RPMI-1640. Then, the neutrophils were fixed with Cytofix (BD Pharmingen) for 5 min. After washing with Pharmingen Stain buffer (bovine serum albumin, BSA) (BD Pharmingen), the neutrophils were stained with Alexa Fluor 488 carboxylic acid succinimidyl ester-conjugated anti-GlyR&#945;2 for 30 min at room temperature. Anti-GlyR&#945;2 antibody was conjugated with Alexa Fluor 488 carboxylic acid succinimidyl ester, in accordance with the manufacturer&#8217;s protocol. Neutrophils were washed in Pharmingen Stain buffer (BSA) (BD Pharmingen) and acquired on Guava Easycyte (GE Healthcare, Chicago, IL, USA). Analysis was performed using FCS Express V3 (De Novo Software, Los Angeles, CA, USA). Alexa 488-conjugated mouse IgG1 (BD Pharmingen) was used as an isotype control. To analyze the surface expression of flavocytochrome b<sub>558</sub>, neutrophils (3 &#215; 10<sup>6</sup>/ml) were stimulated with <italic>E. coli</italic> at a ratio of 1:10 for 20 min in RPMI-1640. Then, the neutrophils were washed with Pharmingen Stain buffer (BSA) (BD Pharmingen) and stained with PE-labeled anti-flavocytochrome b<sub>558</sub> (MBL International, Woburn, MA, USA) for 1 h, and acquired on Guava Easycyte (GE Healthcare). Analysis was performed using FCS Express V3 (De Novo Software).</p>
</sec><sec>
<title>ROS measurement</title>
<p>Intracellular H<sub>2</sub>O<sub>2</sub> levels were measured with a fluorescent probe, 2<sub>&#180;</sub>, 7<sub>&#180;</sub>-dichlorodihydrofluorescein diacetate (DCF-DA), as described previously [<xref rid="ref16" ref-type="bibr">16</xref>]. Neutrophils were allowed to ingest <italic>E. coli</italic> for 20 min. After washing out unengulfed <italic>E. coli</italic>, neutrophils were exposed to vehicle or glycine for the next 15 min in the presence or absence of DPI, further incubated with DCF-DA (10 &#956;M) for 10 min, washed twice with PBS, and then the fluorescence was measured.</p>
</sec><sec>
<title>Fluorescence measurement of Fluo-3</title>
<p>[Ca<sup>2+</sup>]<sub>i</sub> was measured using the fluorescent Ca<sup>2+</sup> indicator Fluo-3. Neutrophils were loaded with Fluo-3 AM (5 &#956;M) in HEPES physiological salt solution (HEPES-PSS) (in mM) (NaCl 140, KCl 5, MgCl<sub>2</sub> 1, CaCl<sub>2</sub> 1, glucose 10, HEPES 10) for 30 min at 37&#176;C. After washing with HEPES-PSS, Fluo-3 AM-loaded neutrophils were resuspended in HEPES-PSS supplemented with 5% FBS and 133 &#956;M glycine and plated on 96-well plates at a cell density of 3 &#215; 10<sup>6</sup>/ml. Traces of intracellular calcium in Fluo-3 AM-loaded neutrophils were measured at 490 nm/526 nm using a Spectramax M2/e fluorescence microplate reader (Molecular Devices, San Jose, CA, USA). Fluorescent emission readings were recorded every 10 sec. Raw fluorescence was subtracted with average fluorescence during the first 5 min. <italic>E. coli</italic> at a ratio of 1:10 was added for 20 min. Then, 1 mM glycine was added.</p>
</sec><sec>
<title>Transfection with microRNA-adapted shRNA of TRPM2</title>
<p>shRNAmir targeting TRPM2 was purchased from Open Biosystems (Huntsville, AL, USA). The sequences were as follows: shRNAmir against TRPM2; 5<sub>&#180;</sub>-TGC-TGT-TGA-CAG-TGA-GCGACC-TGC-TAT-CCT-GGG-AGA-TCT-ATA-GTG-AAG-CCA-CAG-ATG-TATAGA-TCT-CCC-AGG-ATA-GCA-GGG-TGC-CTA-CTG-CCT-CGG-A-3<sub>&#180;</sub>. Neutrophils were transfected with short hairpin RNA using Amaxa Nucleofector Technology (Amaxa Biosystems, Cologne, Germany). Transfection was performed following the manufacturer&#8217;s instructions. In brief, 1 &#215; 10<sup>7</sup> neutrophils were resuspended in human monocyte nucleofector solution (100 &#956;l) (human monocyte transfector kit, cat#VPA-1007; Amaxa Biosystems) at room temperature, followed by the addition of 3 &#956;g of shRNA against TRPM2 or control shRNAmir. Transfection was performed in Amaxa Nucleofector II using program Y-001. Immediately thereafter, neutrophils were diluted in 2.5 ml of human nucleofector medium and incubated for 24 h in a humidified CO<sub>2</sub> incubator.</p>
</sec><sec>
<title>Measurement of Lucifer yellow uptake</title>
<p>Lucifer yellow uptake into neutrophils was measured as described previously [<xref rid="ref17" ref-type="bibr">17</xref>]. Neutrophils (4 &#215; 10<sup>6</sup>/ml) were suspended in Hank&#8217;s balanced salt solution (HBSS) supplemented with 5% FBS and allowed to ingest <italic>E. coli</italic> at a ratio of 1:10 for 20 min. After washing unengulfed <italic>E. coli</italic>, neutrophils were further incubated with glycine or vehicle for 15 min in the presence of Lucifer yellow (0.5 mg/ml). Then, neutrophils were washed two times with cold PBS and lysed with ice-cold double distilled water (DDW) for 1 h. The Lucifer yellow uptake was measured with a Spectramax M2/e fluorescence microplate reader (Molecular Devices) at 428 nm excitation and 536 nm emission.</p>
</sec><sec>
<title>Fusion of azurophil granules and zymosan</title>
<p>Texas red-labeled zymosan particles (Z-2843; Molecular Probes, Eugene, OR, USA) were incubated in 10% human serum for 20 min at 37&#176;C, washed twice with PBS, pH 7.4, and resuspended in PBS. Neutrophils (4 &#215; 10<sup>6</sup>/ml) adhering on glass coverslips were incubated at 37&#176;C for 1 h in a 24-well culture plate. Coverslips were then transferred to a 60-mm dish containing Texas Red-labeled zymosan at a ratio of 1:10. After 20 min, neutrophils were washed to remove most of the extracellular Texas Red-labeled zymosan. Neutrophils were transferred to a 24-well plate and 500 &#956;M glycine was added. After 15 min, experimental samples were washed twice with PBS and fixed using 2% paraformaldehyde for 15 min at room temperature. The cells were then permeabilized using 0.05% Triton X-100 for 10 min at room temperature. After 1 h of blocking in PBS containing 3% BSA, the neutrophils were incubated for 1 h with an anti-CD63 antibody (556019; BD Biosciences, Franklin Lakes, NJ, USA), which was used at a 1:50 dilution in blocking buffer. After 1 h of incubation at room temperature, cells were washed three times in 1 &#215; PBS and incubated for 1 h with Alexa Fluor 488 anti-mouse secondary antibody, used at a final dilution of 1:500. After three washes in 1 &#215; PBS, the cells were mounted using mounting medium. Azurophil granule-phagosome fusion was calculated by measuring the area of co-localization between CD63 (an azurophil granule marker) and zymosan particles, which was divided by the total intracellular zymosan area in confocal images of neutrophils. Stacks of 12&#8211;16 confocal images (each section with 0.52 &#956;M thickness) were collected with an LSM 510 laser-scanning confocal microscope (Carl Zeiss, Jena, Germany). Image analysis was performed using LSM Image Examiner software (Carl Zeiss).</p>
</sec><sec>
<title>Statistical analysis</title>
<p>All of the statistical data were analyzed by GraphPad Prism (GraphPad Software Inc., San Diego, CA, USA). Survival data were analyzed by the log-rank test. All other data were evaluated either by two-tailed Student&#8217;s t-test or by ANOVA. Bonferroni test was used for <italic>post-hoc</italic> comparison. p &#60; 0.05 was considered to indicate statistical significance.</p>
</sec></sec>
<sec sec-type="results">
<title>RESULTS</title>
<sec>
<title>Glycine enhancement of neutrophil bactericidal activity</title>
<p>We examined whether glycine enhances neutrophil bactericidal activity. As shown in <xref rid="F1" ref-type="fig">Fig. 1A</xref>, glycine enhanced neutrophil bactericidal activity in a concentration-dependent manner, with a peak at 500 &#956;M (EC<sub>50</sub> = 238 &#956;M). The glycine enhancement of neutrophil bactericidal activity was blocked by strychnine (a specific GlyR antagonist, 1 &#956;M), indicating the involvement of GlyR in the action of glycine (<xref rid="F1" ref-type="fig">Fig. 1A</xref>). Next, we examined whether systemic administration of glycine increases bacterial clearance <italic>in vivo</italic>. As shown in <xref rid="F1" ref-type="fig">Fig. 1B</xref>, subcutaneous injection of glycine (30 mg/kg) at 30 min after intraperitoneal injection of <italic>E. coli</italic> (5 &#215; 10<sup>8</sup>) significantly decreased the number of CFUs in peritoneal lavage fluid collected 8 h after <italic>E. coli</italic> injection. The effect of glycine was blocked by pretreatment with strychnine (0.4 mg/kg, s.c.) (<xref rid="F1" ref-type="fig">Fig. 1B</xref>).</p>
</sec><sec>
<title>Glycine-induced enhancement of neutrophil bactericidal activity is dependent on enhanced intracellular ROS production</title>
<p>NADPH oxidase and its products ROS play a pivotal role in neutrophil bactericidal activity [<xref rid="ref18" ref-type="bibr">18</xref>,<xref rid="ref19" ref-type="bibr">19</xref>]. Thus, we examined the effect of DPI (1 &#956;M), an inhibitor of NADPH oxidase, on the glycine enhancement of bactericidal activity. As expected, basal bactericidal activity was decreased by DPI (<xref rid="F1" ref-type="fig">Fig. 1C</xref>). Remarkably, the glycine-induced enhancement of bactericidal activity was completely blocked by DPI (<xref rid="F1" ref-type="fig">Fig. 1C</xref>). With the use of DCF-DA, we next examined whether glycine enhances intracellular ROS production in neutrophils that have phagocytosed <italic>E. coli</italic>. Glycine did not affect ROS production in resting neutrophils (<xref rid="F1" ref-type="fig">Fig. 1D</xref>), but it markedly enhanced intracellular ROS production in neutrophils that had phagocytosed <italic>E. coli</italic> in a strychnine-sensitive manner (<xref rid="F1" ref-type="fig">Fig. 1D</xref>).</p>
</sec><sec>
<title>GIyR-ROS-Ca<sup>2+</sup> signaling pathway</title>
<p>[Ca<sup>2+</sup>]<sub>i</sub> in neutrophils is critical for bactericidal activity [<xref rid="ref20" ref-type="bibr">20</xref>]; thus, we examined whether glycine enhances [Ca<sup>2+</sup>]<sub>i</sub> in neutrophils that have phagocytosed <italic>E. coli via</italic> the enhancement of ROS production. Glycine (1 mM) did not affect [Ca<sup>2+</sup>]<sub>i</sub> in resting neutrophils (<xref rid="F1" ref-type="fig">Fig. 1E</xref> left panel, lower tracings). However, glycine (1 mM) markedly enhanced [Ca<sup>2+</sup>]<sub>i</sub> in neutrophils that had phagocytosed <italic>E. coli</italic> (<xref rid="F1" ref-type="fig">Fig. 1E</xref> left panel, upper tracings) in a DPI-sensitive manner (<xref rid="F1" ref-type="fig">Fig. 1E</xref> right panel).</p>
</sec><sec>
<title>Glycine induces <sup>36</sup>CI<sup>&#8211;</sup> uptake and [Ca<sup>2+</sup>]<sub>i</sub> increase in neutrophils pretreated with PMA</title>
<p>To further confirm the GlyR-ROS-Ca<sup>2+</sup> signaling pathway, we used PMA (a protein kinase C activator)-treated neutrophils. PMA (2 &#956;g/ml) induces the release of neutrophil granules and the resultant translocation of proteins in the granule membrane to the plasma membrane [<xref rid="ref21" ref-type="bibr">21</xref>]. In the PMA-treated neutrophils, glycine effectively increased <sup>36</sup>CI<sup>&#8211;</sup> influx (<xref rid="F2" ref-type="fig">Fig. 2A</xref>) and ROS production (<xref rid="F2" ref-type="fig">Fig. 2B</xref>) in a strychnine-sensitive manner. In the PMA-treated neutrophils, glycine-induced a marked increase in [Ca<sup>2+</sup>]<sub>i</sub> (lower tracings), which was inhibited by DPI pretreatment (middle tracings) (<xref rid="F2" ref-type="fig">Fig. 2C</xref>). These results further confirm the GlyR-ROS-Ca<sup>2+</sup> signaling pathway in activated neutrophils.</p>
</sec><sec>
<title>Effects of TRPM2-specific shRNA on glycine (1 mM)-induced increase in [Ca<sup>2+</sup>]<sub>i</sub> in neutrophils, and on glycine (500 &#956;M)-induced enhancement of bactericidal activity</title>
<p>The Ca<sup>2+</sup>-permeable cation channel TRPM2 is abundantly expressed in neutrophils [<xref rid="ref22" ref-type="bibr">22</xref>,<xref rid="ref23" ref-type="bibr">23</xref>]. TRPM2 channel activity is well known to be increased by ROS [<xref rid="ref24" ref-type="bibr">24</xref>,<xref rid="ref25" ref-type="bibr">25</xref>]. Therefore, we examined the involvement of TRPM2 in the effects of glycine. The treatment of neutrophils with TRPM2-specific shRNA effectively decreased the glycine-induced increases in [Ca<sup>2+</sup>]<sub>i</sub> (<xref rid="F3" ref-type="fig">Fig. 3A</xref>), as well as the bactericidal activity in neutrophils (<xref rid="F3" ref-type="fig">Fig. 3B</xref>). Taken together, these results indicate the presence of a GlyR-ROS-Ca<sup>2+</sup> signaling pathway in neutrophils that have phagocytosed <italic>E. coli</italic>.</p>
</sec><sec>
<title>Subcellular localization of GlyR&#945;2 in human neutrophils</title>
<p>Previously, we showed the presence of GlyR in human neutrophils [<xref rid="ref13" ref-type="bibr">13</xref>]. However, the intracellular localization of GlyR in human neutrophils is unknown. To examine the localization of GlyR&#945;2 in human neutrophils, cellular fractionation was carried out using nitrogen cavitation and subcellular fractionation methods [<xref rid="ref21" ref-type="bibr">21</xref>,<xref rid="ref26" ref-type="bibr">26</xref><xref rid="ref27" ref-type="bibr"/>-<xref rid="ref28" ref-type="bibr">28</xref>]. Purified neutrophils were pressurized with N<sub>2</sub> for 20 min at 3350 psi and the supernatant was obtained. Density gradients were prepared over 9 ml of Percoll (1.120 g/ml, 1.090 g/ml, and 1.050 g/ml). The Percoll density gradient following centrifugation revealed four distinct bands. The particulate fractions are referred to as &#945;, &#946;<sub>1</sub>, &#946;<sub>2</sub> and &#947; (less dense), which represent azurophil granules, specific granules, gelatinase granules, and plasma membrane with secretory vesicles, respectively. <xref rid="F4" ref-type="fig">Fig. 4A</xref> clearly shows the localization of GlyR&#945;2 in the &#947;-band, the fraction for secretory vesicles and plasma membranes.</p>
<p>Exposure of neutrophils to PMA or <italic>E. coli</italic> effectively translocates GlyR to the plasma membrane (<xref rid="F4" ref-type="fig">Fig. 4B, C</xref>). The NADPH oxidase comprises cytosolic components and membrane-associated cytochrome b558 (gp91 and phox22 subunits of NADPH oxidase) [<xref rid="ref29" ref-type="bibr">29</xref>]. In resting neutrophils, 15% of cytochrome b558 is localized in the plasma membrane and the remaining 85% in the intracellular granular membrane, chiefly specific granules, and upon activation, translocates to the plasma membrane [<xref rid="ref29" ref-type="bibr">29</xref>]. As expected, the exposure of neutrophils to <italic>E. coli</italic> induced the translocation of cytochrome b<sub>538</sub> to the plasma membrane (<xref rid="F4" ref-type="fig">Fig. 4D</xref>), conferring the basis for cooperation of GlyR and NADPH oxidase.</p>
</sec><sec>
<title>Glycine enhances azurophil granule-phagosome fusion <italic>via</italic> p38 MAPK</title>
<p>Next, we attempted to clarify the cellular events occurring after [Ca<sup>2+</sup>]<sub>i</sub> increase, regarding enhancement of microbicidal activity. Neutrophil azurophil granules contain myeloperoxidase and proteases, which play a critical role in killing microbes [<xref rid="ref30" ref-type="bibr">30</xref>]. Therefore, azurophil granule-phagosome fusion [<xref rid="ref31" ref-type="bibr">31</xref>,<xref rid="ref32" ref-type="bibr">32</xref>] and neutrophil proteases (such as neutrophil elastase and cathepsin G contained mostly in azurophil granules) [<xref rid="ref33" ref-type="bibr">33</xref><xref rid="ref34" ref-type="bibr"/><xref rid="ref35" ref-type="bibr"/>-<xref rid="ref36" ref-type="bibr">36</xref>] are critical for neutrophil bactericidal activity. Furthermore, it was previously demonstrated that azurophil granule release in neutrophils is linked to fluid-phase pinocytosis [<xref rid="ref17" ref-type="bibr">17</xref>]. Thus, we examined whether glycine enhances fluid-phase pinocytosis (by measuring uptake of Lucifer yellow, a water-soluble, membrane-impermeable fluorescent dye) and azurophil granule-phagosome fusion (by measuring the area of co-localization between CD63 [an azurophil granule marker] and zymosan particles, which was divided by the total intracellular zymosan area in confocal images of neutrophils). As shown in <xref rid="F5" ref-type="fig">Fig. 5A and B</xref>, glycine effectively increased Lucifer yellow uptake and azurophil granule-phagosome fusion, which were blocked by strychnine and DPI. These results indicate that glycine-induced enhancement of ROS production (<xref rid="F1" ref-type="fig">Fig. 1D</xref>) is critically involved in the enhancement of Lucifer yellow uptake and azurophil granule-phagosome fusion. Protease inhibitors completely blocked the enhancement of neutrophil bactericidal activity induced by glycine (<xref rid="F5" ref-type="fig">Fig. 5C</xref>).</p>
<p>p38 MAPK is known to be involved in phagosomal maturation in macrophages [<xref rid="ref37" ref-type="bibr">37</xref>], fluid-phase pinocytosis [<xref rid="ref38" ref-type="bibr">38</xref>], and translocation of the intracellular cytochrome b558 (a component of NADPH oxidase) to the plasma membrane in neutrophils [<xref rid="ref39" ref-type="bibr">39</xref>]. Thus, we examined the effect of the p38 MAPK inhibitor SB203580 on glycine-induced increases in Lucifer yellow uptake, azurophil granule-phagosome fusion, and bactericidal activity. As shown in <xref rid="F5" ref-type="fig">Fig. 5A&#8211;C</xref>, SB203580 completely blocked glycine-induced enhancement of all of these parameters. The lack of effect of p38 MAPK inhibition by SB203580 on basal microbicidal activity (<xref rid="F5" ref-type="fig">Fig. 5C</xref>) is in agreement with previous reports [<xref rid="ref40" ref-type="bibr">40</xref>,<xref rid="ref41" ref-type="bibr">41</xref>].</p>
</sec></sec>
<sec sec-type="discussion">
<title>DISCUSSION</title>
<p>In this study, we found a novel mechanism for the enhancement of neutrophil bactericidal activity (<xref rid="F6" ref-type="fig">Fig. 6</xref>), in which intracellular GlyR&#945;2 translocates to the plasma membrane (<xref rid="F4" ref-type="fig">Fig. 4B, C</xref>) and glycine acts <italic>via</italic> GlyR&#945;2 to induce chloride influx (<xref rid="F2" ref-type="fig">Fig. 2A</xref>). The subsequent signaling mechanism couples the chloride influx to the enhancement of NADPH oxidase activity (the cytochrome b558 component Nox also translocates to the plasma membrane in neutrophils that have phagocytosed <italic>E. coli</italic>), resulting in increased ROS production (<xref rid="F1" ref-type="fig">Fig. 1D</xref>). This elevated ROS production increases TRPM2 channel activity, resulting in [Ca<sup>2+</sup>]<sub>i</sub> increase (<xref rid="F1" ref-type="fig">Figs. 1E</xref> left panel, 2C, 3A). Subsequent cascading events include p38 MAPK activation, and enhancement of fluid-phase pinocytosis, azurophil granule-phagosome fusion, and bactericidal activity (<xref rid="F5" ref-type="fig">Fig. 5</xref>). However, it is to be noted that the GlyR&#945;2/TRPM2/p38 MAPK signal is not critically involved in basal bactericidal activity, but can be mobilized for boosting the bactericidal activity of neutrophils when neutrophils are stimulated by glycine.</p>
<p>NADPH oxidase is essential for neutrophil microbicidal activity [<xref rid="ref29" ref-type="bibr">29</xref>]. We detected glycine/GlyR-mediated enhancement of NADPH oxidase activity in <italic>E. coli</italic>-treated neutrophils, but not in resting neutrophils (<xref rid="F1" ref-type="fig">Fig. 1D</xref>), indicating that GlyR is not involved in the basal phagocytosis-associated respiratory burst but only in the enhancement of it induced by supplemental glycine. Impaired NADPH oxidase activity is known to be accompanied by impairment in release of azurophil granules that contain various proteases, and protease activity; both chronic granulomatous disease neutrophils and DPI-treated neutrophils show impairment in azurophil granule release [<xref rid="ref42" ref-type="bibr">42</xref><xref rid="ref43" ref-type="bibr"/>-<xref rid="ref44" ref-type="bibr">44</xref>] and in the digestion of killed <italic>E. coli</italic> [<xref rid="ref36" ref-type="bibr">36</xref>,<xref rid="ref45" ref-type="bibr">45</xref>,<xref rid="ref46" ref-type="bibr">46</xref>]. We found that ROS was essential in glycine-induced azurophil granule-phagosome fusion <italic>via</italic> the Ca<sup>2+</sup>/p38 MAPK/fluid-phase pinocytosis/azurophil granule-phagosome fusion pathway. This finding reveals a clear mechanism for the inter-relationship between ROS and proteases in neutrophil bactericidal activity. Specifically, the blocking effect of DPI on glycine-induced enhancement of azurophil granule-phagosome fusion (<xref rid="F5" ref-type="fig">Fig. 5B</xref>) provides a mechanism for the cooperation of ROS and protease action, two important microbicidal effectors of neutrophils [<xref rid="ref47" ref-type="bibr">47</xref>].</p>
<p>Interestingly, LPC translocates GlyR to the plasma membrane, and induces glycine/GlyR-mediated enhancement of neutrophil bactericidal activity [<xref rid="ref13" ref-type="bibr">13</xref>]. These results suggest that the translocation of intracellular GlyR to the neutrophil plasma membrane is a commonality of signaling for neutrophil stimulators. However, a difference between glycine (<xref rid="F1" ref-type="fig">Fig. 1C</xref>) and LPC [<xref rid="ref13" ref-type="bibr">13</xref>] was noted in the sensitivity of their bactericidal activity-enhancing effect on DPI. Further studies are needed to elucidate their shared as well as disparate intracellular signaling pathways.</p>
<p>The administration of glycine (30 mg/kg) to mice that had been intraperitoneally given <italic>E. coli</italic> enhanced bacterial clearance (<xref rid="F1" ref-type="fig">Fig. 1B</xref>). The reported physiological plasma concentration of glycine (&#126; 250 &#956;M) in mice [<xref rid="ref48" ref-type="bibr">48</xref>] as well as in humans [<xref rid="ref49" ref-type="bibr">49</xref>] is below 500 &#956;M, the optimum glycine concentration for bactericidal activity (<xref rid="F1" ref-type="fig">Fig. 1A</xref>). In fact, strychnine affected neither basal neutrophil bactericidal activity <italic>in vitro</italic> (where the glycine concentration in RPMI medium is 133 &#956;M) (<xref rid="F1" ref-type="fig">Fig. 1A</xref>), nor basal bacterial clearance in mice challenged with the intraperitoneal administration of <italic>E. coli</italic> (<xref rid="F1" ref-type="fig">Fig. 1B</xref>), probably due to an insufficient concentration of glycine. Therefore, boosting GlyR activation in neutrophils by glycine supplementation (<xref rid="F1" ref-type="fig">Fig. 1A, B</xref>) could be beneficial for treating of serious microbial infectious disorders, especially when direct-acting antimicrobials are not sufficiently effective. Together, our findings suggest neutrophil GlyR&#945;2 as a novel target in the fight against microbes.</p>
</sec>
</body>
<back>
<ack>
<title>ACKNOWLEDGEMENTS</title>
<p>None.</p>
</ack>
<fn-group>
<fn fn-type="supported-by">
<p><bold>FUNDING</bold></p>
<p>This research was supported by the Basic Research Program of the National Research Foundation of Korea (NRF), funded by the Ministry of Science ICT (NRF-2020R1F1A1067708).</p>
</fn>
<fn fn-type="conflict">
<p><bold>CONFLICTS OF INTEREST</bold></p>
<p>The authors declare no conflicts of interest.</p>
</fn>
</fn-group>
<ref-list>
<title>REFERENCES</title>
<ref id="ref1">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Segal</surname><given-names>AW</given-names></name>
</person-group>
<year>2005</year>
<article-title>How neutrophils kill microbes</article-title>
<source>Annu Rev Immunol</source>
<volume>23</volume>
<fpage>197</fpage>
<lpage>223</lpage>
<pub-id pub-id-type="doi">10.1146/annurev.immunol.23.021704.115653</pub-id>
<pub-id pub-id-type="pmid">15771570</pub-id>
<pub-id pub-id-type="pmcid">PMC2092448</pub-id>
<pub-id pub-id-type="other">https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&#38;scp=17644377258&#38;origin=inward</pub-id>
</element-citation>
</ref>
<ref id="ref2">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Burn</surname><given-names>GL</given-names></name>
<name><surname>Foti</surname><given-names>A</given-names></name>
<name><surname>Marsman</surname><given-names>G</given-names></name>
<name><surname>Patel</surname><given-names>DF</given-names></name>
<name><surname>Zychlinsky</surname><given-names>A</given-names></name>
</person-group>
<year>2021</year>
<article-title>The Neutrophil</article-title>
<source>Immunity</source>
<volume>54</volume>
<fpage>1377</fpage>
<lpage>1391</lpage>
<pub-id pub-id-type="doi">10.1016/j.immuni.2021.06.006</pub-id>
<pub-id pub-id-type="pmid">34260886</pub-id>
<pub-id pub-id-type="other">https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&#38;scp=85111770558&#38;origin=inward</pub-id>
</element-citation>
</ref>
<ref id="ref3">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Alexander</surname><given-names>JW</given-names></name>
<name><surname>Meakins</surname><given-names>JL</given-names></name>
</person-group>
<year>1972</year>
<article-title>A physiological basis for the development of opportunistic infections in man</article-title>
<source>Ann Surg</source>
<volume>176</volume>
<fpage>273</fpage>
<lpage>287</lpage>
<pub-id pub-id-type="doi">10.1097/00000658-197209000-00003</pub-id>
<pub-id pub-id-type="pmid">4561323</pub-id>
<pub-id pub-id-type="pmcid">PMC1355390</pub-id>
<pub-id pub-id-type="other">https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&#38;scp=0015402530&#38;origin=inward</pub-id>
</element-citation>
</ref>
<ref id="ref4">
<label>4</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Solberg</surname><given-names>CO</given-names></name>
<name><surname>Hellum</surname><given-names>KB</given-names></name>
</person-group>
<year>1972</year>
<article-title>Neutrophil granulocyte function in bacterial infections</article-title>
<source>Lancet</source>
<volume>2</volume>
<fpage>727</fpage>
<lpage>730</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(72)92022-3</pub-id>
<pub-id pub-id-type="pmid">4116144</pub-id>
<pub-id pub-id-type="other">https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&#38;scp=0015497270&#38;origin=inward</pub-id>
</element-citation>
</ref>
<ref id="ref5">
<label>5</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Christou</surname><given-names>NV</given-names></name>
<name><surname>Meakins</surname><given-names>JL</given-names></name>
</person-group>
<year>1979</year>
<article-title>Neutrophil function in anergic surgical patients: neutrophil adherence and chemotaxis</article-title>
<source>Ann Surg</source>
<volume>190</volume>
<fpage>557</fpage>
<lpage>564</lpage>
<pub-id pub-id-type="doi">10.1097/00000658-197911000-00001</pub-id>
<pub-id pub-id-type="pmid">507967</pub-id>
<pub-id pub-id-type="pmcid">PMC1344532</pub-id>
<pub-id pub-id-type="other">https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&#38;scp=0018736120&#38;origin=inward</pub-id>
</element-citation>
</ref>
<ref id="ref6">
<label>6</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Solomkin</surname><given-names>JS</given-names></name>
<name><surname>Bauman</surname><given-names>MP</given-names></name>
<name><surname>Nelson</surname><given-names>RD</given-names></name>
<name><surname>Simmons</surname><given-names>RL</given-names></name>
</person-group>
<year>1981</year>
<article-title>Neutrophils dysfunction during the course of intra-abdominal infection</article-title>
<source>Ann Surg</source>
<volume>194</volume>
<fpage>9</fpage>
<lpage>17</lpage>
<pub-id pub-id-type="doi">10.1097/00000658-198107000-00003</pub-id>
<pub-id pub-id-type="pmid">7247540</pub-id>
<pub-id pub-id-type="pmcid">PMC1345188</pub-id>
<pub-id pub-id-type="other">https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&#38;scp=0019792357&#38;origin=inward</pub-id>
</element-citation>
</ref>
<ref id="ref7">
<label>7</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Solomkin</surname><given-names>JS</given-names></name>
<name><surname>Cotta</surname><given-names>LA</given-names></name>
<name><surname>Brodt</surname><given-names>JK</given-names></name>
<name><surname>Hurst</surname><given-names>JW</given-names></name>
<name><surname>Ogle</surname><given-names>CK</given-names></name>
</person-group>
<year>1984</year>
<article-title>Neutrophil dysfunction in sepsis. III. Degranulation as a mechanism for nonspecific deactivation</article-title>
<source>J Surg Res</source>
<volume>36</volume>
<fpage>407</fpage>
<lpage>412</lpage>
<pub-id pub-id-type="doi">10.1016/0022-4804(84)90119-7</pub-id>
<pub-id pub-id-type="pmid">6328115</pub-id>
<pub-id pub-id-type="other">https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&#38;scp=0021276177&#38;origin=inward</pub-id>
</element-citation>
</ref>
<ref id="ref8">
<label>8</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Czermak</surname><given-names>BJ</given-names></name>
<name><surname>Sarma</surname><given-names>V</given-names></name>
<name><surname>Pierson</surname><given-names>CL</given-names></name>
<name><surname>Warner</surname><given-names>RL</given-names></name>
<name><surname>Huber-Lang</surname><given-names>M</given-names></name>
<name><surname>Bless</surname><given-names>NM</given-names></name>
<name><surname>Schmal</surname><given-names>H</given-names></name>
<name><surname>Friedl</surname><given-names>HP</given-names></name>
<name><surname>Ward</surname><given-names>PA</given-names></name>
</person-group>
<year>1999</year>
<article-title>Protective effects of C5a blockade in sepsis</article-title>
<source>Nat Med</source>
<volume>5</volume>
<fpage>788</fpage>
<lpage>792</lpage>
<pub-id pub-id-type="doi">10.1038/10512</pub-id>
<pub-id pub-id-type="pmid">10395324</pub-id>
<pub-id pub-id-type="other">https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&#38;scp=0033052453&#38;origin=inward</pub-id>
</element-citation>
</ref>
<ref id="ref9">
<label>9</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Tavares-Murta</surname><given-names>BM</given-names></name>
<name><surname>Zaparoli</surname><given-names>M</given-names></name>
<name><surname>Ferreira</surname><given-names>RB</given-names></name>
<name><surname>Silva-Vergara</surname><given-names>ML</given-names></name>
<name><surname>Oliveira</surname><given-names>CH</given-names></name>
<name><surname>Murta</surname><given-names>EF</given-names></name>
<name><surname>Ferreira</surname><given-names>SH</given-names></name>
<name><surname>Cunha</surname><given-names>FQ</given-names></name>
</person-group>
<year>2002</year>
<article-title>Failure of neutrophil chemotactic function in septic patients</article-title>
<source>Crit Care Med</source>
<volume>30</volume>
<fpage>1056</fpage>
<lpage>1061</lpage>
<pub-id pub-id-type="doi">10.1097/00003246-200205000-00017</pub-id>
<pub-id pub-id-type="pmid">12006803</pub-id>
<pub-id pub-id-type="other">https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&#38;scp=0036256051&#38;origin=inward</pub-id>
</element-citation>
</ref>
<ref id="ref10">
<label>10</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kaufmann</surname><given-names>I</given-names></name>
<name><surname>Hoelzl</surname><given-names>A</given-names></name>
<name><surname>Schliephake</surname><given-names>F</given-names></name>
<name><surname>Hummel</surname><given-names>T</given-names></name>
<name><surname>Chouker</surname><given-names>A</given-names></name>
<name><surname>Peter</surname><given-names>K</given-names></name>
<name><surname>Thiel</surname><given-names>M</given-names></name>
</person-group>
<year>2006</year>
<article-title>Polymorphonuclear leukocyte dysfunction syndrome in patients with increasing sepsis severity</article-title>
<source>Shock</source>
<volume>26</volume>
<fpage>254</fpage>
<lpage>261</lpage>
<pub-id pub-id-type="doi">10.1097/01.shk.0000223131.64512.7a</pub-id>
<pub-id pub-id-type="pmid">16912650</pub-id>
<pub-id pub-id-type="other">https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&#38;scp=33747330314&#38;origin=inward</pub-id>
</element-citation>
</ref>
<ref id="ref11">
<label>11</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Stephan</surname><given-names>F</given-names></name>
<name><surname>Yang</surname><given-names>K</given-names></name>
<name><surname>Tankovic</surname><given-names>J</given-names></name>
<name><surname>Soussy</surname><given-names>CJ</given-names></name>
<name><surname>Dhonneur</surname><given-names>G</given-names></name>
<name><surname>Duvaldestin</surname><given-names>P</given-names></name>
<name><surname>Brochard</surname><given-names>L</given-names></name>
<name><surname>Brun-Buisson</surname><given-names>C</given-names></name>
<name><surname>Harf</surname><given-names>A</given-names></name>
<name><surname>Delclaux</surname><given-names>C</given-names></name>
</person-group>
<year>2002</year>
<article-title>Impairment of polymorphonuclear neutrophil functions precedes nosocomial infections in critically ill patients</article-title>
<source>Crit Care Med</source>
<volume>30</volume>
<fpage>315</fpage>
<lpage>322</lpage>
<pub-id pub-id-type="doi">10.1097/00003246-200202000-00009</pub-id>
<pub-id pub-id-type="pmid">11889301</pub-id>
<pub-id pub-id-type="other">https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&#38;scp=0036172413&#38;origin=inward</pub-id>
</element-citation>
</ref>
<ref id="ref12">
<label>12</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Liles</surname><given-names>WC</given-names></name>
</person-group>
<year>2001</year>
<article-title>Immunomodulatory approaches to augment phagocyte-mediated host defense for treatment of infectious diseases</article-title>
<source>Semin Respir Infect</source>
<volume>16</volume>
<fpage>11</fpage>
<lpage>17</lpage>
<pub-id pub-id-type="doi">10.1053/srin.2001.22724</pub-id>
<pub-id pub-id-type="pmid">11309708</pub-id>
<pub-id pub-id-type="other">https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&#38;scp=0035069871&#38;origin=inward</pub-id>
</element-citation>
</ref>
<ref id="ref13">
<label>13</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Hong</surname><given-names>CW</given-names></name>
<name><surname>Kim</surname><given-names>TK</given-names></name>
<name><surname>Ham</surname><given-names>HY</given-names></name>
<name><surname>Nam</surname><given-names>JS</given-names></name>
<name><surname>Kim</surname><given-names>YH</given-names></name>
<name><surname>Zheng</surname><given-names>H</given-names></name>
<name><surname>Pang</surname><given-names>B</given-names></name>
<name><surname>Min</surname><given-names>TK</given-names></name>
<name><surname>Jung</surname><given-names>JS</given-names></name>
<name><surname>Lee</surname><given-names>SN</given-names></name>
<name><surname>Cho</surname><given-names>HJ</given-names></name>
<name><surname>Kim</surname><given-names>EJ</given-names></name>
<name><surname>Hong</surname><given-names>IH</given-names></name>
<name><surname>Kang</surname><given-names>TC</given-names></name>
<name><surname>Lee</surname><given-names>J</given-names></name>
<name><surname>Oh</surname><given-names>SB</given-names></name>
<name><surname>Jung</surname><given-names>SJ</given-names></name>
<name><surname>Kim</surname><given-names>SJ</given-names></name>
<name><surname>Song</surname><given-names>DK</given-names></name>
</person-group>
<year>2010</year>
<article-title>Lysophosphatidylcholine increases neutrophil bactericidal activity by enhancement of azurophil granule-phagosome fusion via glycine.GlyR alpha 2/TRPM2/p38 MAPK signaling</article-title>
<source>J Immunol</source>
<volume>184</volume>
<fpage>4401</fpage>
<lpage>4413</lpage>
<pub-id pub-id-type="doi">10.4049/jimmunol.0902814</pub-id>
<pub-id pub-id-type="pmid">20237295</pub-id>
<pub-id pub-id-type="other">https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&#38;scp=77952751229&#38;origin=inward</pub-id>
</element-citation>
</ref>
<ref id="ref14">
<label>14</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Yan</surname><given-names>JJ</given-names></name>
<name><surname>Jung</surname><given-names>JS</given-names></name>
<name><surname>Lee</surname><given-names>JE</given-names></name>
<name><surname>Lee</surname><given-names>J</given-names></name>
<name><surname>Huh</surname><given-names>SO</given-names></name>
<name><surname>Kim</surname><given-names>HS</given-names></name>
<name><surname>Jung</surname><given-names>KC</given-names></name>
<name><surname>Cho</surname><given-names>JY</given-names></name>
<name><surname>Nam</surname><given-names>JS</given-names></name>
<name><surname>Suh</surname><given-names>HW</given-names></name>
<name><surname>Kim</surname><given-names>YH</given-names></name>
<name><surname>Song</surname><given-names>DK</given-names></name>
</person-group>
<year>2004</year>
<article-title>Therapeutic effects of lysophosphatidylcholine in experimental sepsis</article-title>
<source>Nat Med</source>
<volume>10</volume>
<fpage>161</fpage>
<lpage>167</lpage>
<pub-id pub-id-type="doi">10.1038/nm989</pub-id>
<pub-id pub-id-type="pmid">14716308</pub-id>
<pub-id pub-id-type="other">https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&#38;scp=11144354207&#38;origin=inward</pub-id>
</element-citation>
</ref>
<ref id="ref15">
<label>15</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Blednov</surname><given-names>YA</given-names></name>
<name><surname>Bleck</surname><given-names>V</given-names></name>
<name><surname>Harris</surname><given-names>RA</given-names></name>
</person-group>
<year>1996</year>
<article-title>Measurement of glycine receptor function by radioactive chloride uptake</article-title>
<source>J Neurosci Methods</source>
<volume>68</volume>
<fpage>253</fpage>
<lpage>257</lpage>
<pub-id pub-id-type="doi">10.1016/0165-0270(96)00088-X</pub-id>
<pub-id pub-id-type="pmid">8912198</pub-id>
<pub-id pub-id-type="other">https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&#38;scp=0030273551&#38;origin=inward</pub-id>
</element-citation>
</ref>
<ref id="ref16">
<label>16</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Sturn</surname><given-names>DH</given-names></name>
<name><surname>Kaneider</surname><given-names>NC</given-names></name>
<name><surname>Feistritzer</surname><given-names>C</given-names></name>
<name><surname>Djanani</surname><given-names>A</given-names></name>
<name><surname>Fukudome</surname><given-names>K</given-names></name>
<name><surname>Wiedermann</surname><given-names>CJ</given-names></name>
</person-group>
<year>2003</year>
<article-title>Expression and function of the endothelial protein C receptor in human neutrophils</article-title>
<source>Blood</source>
<volume>102</volume>
<fpage>1499</fpage>
<lpage>1505</lpage>
<pub-id pub-id-type="doi">10.1182/blood-2002-12-3880</pub-id>
<pub-id pub-id-type="pmid">12714492</pub-id>
<pub-id pub-id-type="other">https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&#38;scp=0043240071&#38;origin=inward</pub-id>
</element-citation>
</ref>
<ref id="ref17">
<label>17</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Fittschen</surname><given-names>C</given-names></name>
<name><surname>Henson</surname><given-names>PM</given-names></name>
</person-group>
<year>1994</year>
<article-title>Linkage of azurophil granule secretion in neutrophils to chloride ion transport and endosomal transcytosis</article-title>
<source>J Clin Invest</source>
<volume>93</volume>
<fpage>247</fpage>
<lpage>255</lpage>
<pub-id pub-id-type="doi">10.1172/JCI116952</pub-id>
<pub-id pub-id-type="pmid">8282794</pub-id>
<pub-id pub-id-type="pmcid">PMC293759</pub-id>
<pub-id pub-id-type="other">https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&#38;scp=0028123331&#38;origin=inward</pub-id>
</element-citation>
</ref>
<ref id="ref18">
<label>18</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Roos</surname><given-names>D</given-names></name>
<name><surname>van Bruggen</surname><given-names>R</given-names></name>
<name><surname>Meischl</surname><given-names>C</given-names></name>
</person-group>
<year>2003</year>
<article-title>Oxidative killing of microbes by neutrophils</article-title>
<source>Microbes Infect</source>
<volume>5</volume>
<fpage>1307</fpage>
<lpage>1315</lpage>
<pub-id pub-id-type="doi">10.1016/j.micinf.2003.09.009</pub-id>
<pub-id pub-id-type="pmid">14613774</pub-id>
<pub-id pub-id-type="other">https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&#38;scp=0242460542&#38;origin=inward</pub-id>
</element-citation>
</ref>
<ref id="ref19">
<label>19</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Winterbourn</surname><given-names>CC</given-names></name>
<name><surname>Kettle</surname><given-names>AJ</given-names></name>
<name><surname>Hampton</surname><given-names>MB</given-names></name>
</person-group>
<year>2016</year>
<article-title>Reactive oxygen species and neutrophil function</article-title>
<source>Annu Rev Biochem</source>
<volume>85</volume>
<fpage>765</fpage>
<lpage>792</lpage>
<pub-id pub-id-type="doi">10.1146/annurev-biochem-060815-014442</pub-id>
<pub-id pub-id-type="pmid">27050287</pub-id>
<pub-id pub-id-type="other">https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&#38;scp=84974721064&#38;origin=inward</pub-id>
</element-citation>
</ref>
<ref id="ref20">
<label>20</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Wilsson</surname><given-names>A</given-names></name>
<name><surname>Lundqvist</surname><given-names>H</given-names></name>
<name><surname>Gustafsson</surname><given-names>M</given-names></name>
<name><surname>Stendahl</surname><given-names>O</given-names></name>
</person-group>
<year>1996</year>
<article-title>Killing of phagocytosed Staphylococcus aureus by human neutrophils requires intracellular free calcium</article-title>
<source>J Leukoc Biol</source>
<volume>59</volume>
<fpage>902</fpage>
<lpage>907</lpage>
<pub-id pub-id-type="doi">10.1002/jlb.59.6.902</pub-id>
<pub-id pub-id-type="pmid">8691076</pub-id>
<pub-id pub-id-type="other">https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&#38;scp=0029974262&#38;origin=inward</pub-id>
</element-citation>
</ref>
<ref id="ref21">
<label>21</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kjeldsen</surname><given-names>L</given-names></name>
<name><surname>Sengelov</surname><given-names>H</given-names></name>
<name><surname>Borregaard</surname><given-names>N</given-names></name>
</person-group>
<year>1999</year>
<article-title>Subcellular fractionation of human neutrophils on Percoll density gradients</article-title>
<source>J Immunol Methods</source>
<volume>232</volume>
<fpage>131</fpage>
<lpage>143</lpage>
<pub-id pub-id-type="doi">10.1016/S0022-1759(99)00171-4</pub-id>
<pub-id pub-id-type="pmid">10618515</pub-id>
<pub-id pub-id-type="other">https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&#38;scp=0033386768&#38;origin=inward</pub-id>
</element-citation>
</ref>
<ref id="ref22">
<label>22</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Heiner</surname><given-names>I</given-names></name>
<name><surname>Eisfeld</surname><given-names>J</given-names></name>
<name><surname>L&#252;ckhoff</surname><given-names>A</given-names></name>
</person-group>
<year>2003</year>
<article-title>Role and regulation of TRP channels in neutrophil granulocytes</article-title>
<source>Cell Calcium</source>
<volume>33</volume>
<fpage>533</fpage>
<lpage>540</lpage>
<pub-id pub-id-type="doi">10.1016/S0143-4160(03)00058-7</pub-id>
<pub-id pub-id-type="pmid">12765698</pub-id>
<pub-id pub-id-type="other">https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&#38;scp=0037974386&#38;origin=inward</pub-id>
</element-citation>
</ref>
<ref id="ref23">
<label>23</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Heiner</surname><given-names>I</given-names></name>
<name><surname>Eisfeld</surname><given-names>J</given-names></name>
<name><surname>Warnstedt</surname><given-names>M</given-names></name>
<name><surname>Radukina</surname><given-names>N</given-names></name>
<name><surname>J&#252;ngling</surname><given-names>E</given-names></name>
<name><surname>L&#252;ckhoff</surname><given-names>A</given-names></name>
</person-group>
<year>2006</year>
<article-title>Endogenous ADP-ribose enables calcium-regulated cation currents through TRPM2 channels in neutrophil granulocytes</article-title>
<source>Biochem J</source>
<volume>398</volume>
<fpage>225</fpage>
<lpage>232</lpage>
<pub-id pub-id-type="doi">10.1042/BJ20060183</pub-id>
<pub-id pub-id-type="pmid">16719842</pub-id>
<pub-id pub-id-type="pmcid">PMC1550310</pub-id>
<pub-id pub-id-type="other">https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&#38;scp=33748336294&#38;origin=inward</pub-id>
</element-citation>
</ref>
<ref id="ref24">
<label>24</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Hara</surname><given-names>Y</given-names></name>
<name><surname>Wakamori</surname><given-names>M</given-names></name>
<name><surname>Ishii</surname><given-names>M</given-names></name>
<name><surname>Maeno</surname><given-names>E</given-names></name>
<name><surname>Nishida</surname><given-names>M</given-names></name>
<name><surname>Yoshida</surname><given-names>T</given-names></name>
<name><surname>Yamada</surname><given-names>H</given-names></name>
<name><surname>Shimizu</surname><given-names>S</given-names></name>
<name><surname>Mori</surname><given-names>E</given-names></name>
<name><surname>Kudoh</surname><given-names>J</given-names></name>
<name><surname>Shimizu</surname><given-names>N</given-names></name>
<name><surname>Kurose</surname><given-names>H</given-names></name>
<name><surname>Okada</surname><given-names>Y</given-names></name>
<name><surname>Imoto</surname><given-names>K</given-names></name>
<name><surname>Mori</surname><given-names>Y</given-names></name>
</person-group>
<year>2002</year>
<article-title>LTRPC2 Ca<sup>2+</sup>-permeable channel activated by changes in redox status confers susceptibility to cell death</article-title>
<source>Mol Cell</source>
<volume>9</volume>
<fpage>163</fpage>
<lpage>173</lpage>
<pub-id pub-id-type="doi">10.1016/S1097-2765(01)00438-5</pub-id>
<pub-id pub-id-type="pmid">11804595</pub-id>
<pub-id pub-id-type="other">https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&#38;scp=18244391511&#38;origin=inward</pub-id>
</element-citation>
</ref>
<ref id="ref25">
<label>25</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Wehage</surname><given-names>E</given-names></name>
<name><surname>Eisfeld</surname><given-names>J</given-names></name>
<name><surname>Heiner</surname><given-names>I</given-names></name>
<name><surname>J&#252;ngling</surname><given-names>E</given-names></name>
<name><surname>Zitt</surname><given-names>C</given-names></name>
<name><surname>L&#252;ckhoff</surname><given-names>A</given-names></name>
</person-group>
<year>2002</year>
<article-title>Activation of the cation channel long transient receptor potential channel 2 (LTRPC2) by hydrogen peroxide. A splice variant reveals a mode of activation independent of ADP-ribose</article-title>
<source>J Biol Chem</source>
<volume>277</volume>
<fpage>23150</fpage>
<lpage>23156</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M112096200</pub-id>
<pub-id pub-id-type="pmid">11960981</pub-id>
<pub-id pub-id-type="other">https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&#38;scp=0037189484&#38;origin=inward</pub-id>
</element-citation>
</ref>
<ref id="ref26">
<label>26</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Klempner</surname><given-names>MS</given-names></name>
<name><surname>Mikkelsen</surname><given-names>RB</given-names></name>
<name><surname>Corfman</surname><given-names>DH</given-names></name>
<name><surname>Andr&#233;-Schwartz</surname><given-names>J</given-names></name>
</person-group>
<year>1980</year>
<article-title>Neutrophil plasma membranes. I. High-yield purification of human neutrophil plasma membrane vesicles by nitrogen cavitation and differential centrifugation</article-title>
<source>J Cell Biol</source>
<volume>86</volume>
<fpage>21</fpage>
<lpage>28</lpage>
<pub-id pub-id-type="doi">10.1083/jcb.86.1.21</pub-id>
<pub-id pub-id-type="pmid">7419575</pub-id>
<pub-id pub-id-type="pmcid">PMC2110662</pub-id>
<pub-id pub-id-type="other">https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&#38;scp=0019312005&#38;origin=inward</pub-id>
</element-citation>
</ref>
<ref id="ref27">
<label>27</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Borregaard</surname><given-names>N</given-names></name>
<name><surname>Heiple</surname><given-names>JM</given-names></name>
<name><surname>Simons</surname><given-names>ER</given-names></name>
<name><surname>Clark</surname><given-names>RA</given-names></name>
</person-group>
<year>1983</year>
<article-title>Subcellular localization of the b-cytochrome component of the human neutrophil microbicidal oxidase: translocation during activation</article-title>
<source>J Cell Biol</source>
<volume>97</volume>
<fpage>52</fpage>
<lpage>61</lpage>
<pub-id pub-id-type="doi">10.1083/jcb.97.1.52</pub-id>
<pub-id pub-id-type="pmid">6408102</pub-id>
<pub-id pub-id-type="pmcid">PMC2112494</pub-id>
<pub-id pub-id-type="other">https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&#38;scp=0020540731&#38;origin=inward</pub-id>
</element-citation>
</ref>
<ref id="ref28">
<label>28</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Moreland</surname><given-names>JG</given-names></name>
<name><surname>Davis</surname><given-names>AP</given-names></name>
<name><surname>Bailey</surname><given-names>G</given-names></name>
<name><surname>Nauseef</surname><given-names>WM</given-names></name>
<name><surname>Lamb</surname><given-names>FS</given-names></name>
</person-group>
<year>2006</year>
<article-title>Anion channels, including ClC-3, are required for normal neutrophil oxidative function, phagocytosis, and transendothelial migration</article-title>
<source>J Biol Chem</source>
<volume>281</volume>
<fpage>12277</fpage>
<lpage>12288</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M511030200</pub-id>
<pub-id pub-id-type="pmid">16522634</pub-id>
<pub-id pub-id-type="other">https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&#38;scp=33744963881&#38;origin=inward</pub-id>
</element-citation>
</ref>
<ref id="ref29">
<label>29</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Sheppard</surname><given-names>FR</given-names></name>
<name><surname>Kelher</surname><given-names>MR</given-names></name>
<name><surname>Moore</surname><given-names>EE</given-names></name>
<name><surname>McLaughlin</surname><given-names>NJ</given-names></name>
<name><surname>Banerjee</surname><given-names>A</given-names></name>
<name><surname>Silliman</surname><given-names>CC</given-names></name>
</person-group>
<year>2005</year>
<article-title>Structural organization of the neutrophil NADPH oxidase: phosphorylation and translocation during priming and activation</article-title>
<source>J Leukoc Biol</source>
<volume>78</volume>
<fpage>1025</fpage>
<lpage>1042</lpage>
<pub-id pub-id-type="doi">10.1189/jlb.0804442</pub-id>
<pub-id pub-id-type="pmid">16204621</pub-id>
<pub-id pub-id-type="other">https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&#38;scp=27644514297&#38;origin=inward</pub-id>
</element-citation>
</ref>
<ref id="ref30">
<label>30</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Borregaard</surname><given-names>N</given-names></name>
<name><surname>S&#248;rensen</surname><given-names>OE</given-names></name>
<name><surname>Theilgaard-M&#246;nch</surname><given-names>K</given-names></name>
</person-group>
<year>2007</year>
<article-title>Neutrophil granules: a library of innate immunity proteins</article-title>
<source>Trends Immunol</source>
<volume>28</volume>
<fpage>340</fpage>
<lpage>345</lpage>
<pub-id pub-id-type="doi">10.1016/j.it.2007.06.002</pub-id>
<pub-id pub-id-type="pmid">17627888</pub-id>
<pub-id pub-id-type="other">https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&#38;scp=34447561633&#38;origin=inward</pub-id>
</element-citation>
</ref>
<ref id="ref31">
<label>31</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Abramson</surname><given-names>JS</given-names></name>
<name><surname>Lewis</surname><given-names>JC</given-names></name>
<name><surname>Lyles</surname><given-names>DS</given-names></name>
<name><surname>Heller</surname><given-names>KA</given-names></name>
<name><surname>Mills</surname><given-names>EL</given-names></name>
<name><surname>Bass</surname><given-names>DA</given-names></name>
</person-group>
<year>1982</year>
<article-title>Inhibition of neutrophil lysosome-phagosome fusion associated with influenza virus infection in vitro. Role in depressed bactericidal activity</article-title>
<source>J Clin Invest</source>
<volume>69</volume>
<fpage>1393</fpage>
<lpage>1397</lpage>
<pub-id pub-id-type="doi">10.1172/JCI110580</pub-id>
<pub-id pub-id-type="pmid">7085879</pub-id>
<pub-id pub-id-type="pmcid">PMC370213</pub-id>
<pub-id pub-id-type="other">https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&#38;scp=0019968304&#38;origin=inward</pub-id>
</element-citation>
</ref>
<ref id="ref32">
<label>32</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Staali</surname><given-names>L</given-names></name>
<name><surname>Bauer</surname><given-names>S</given-names></name>
<name><surname>M&#246;rgelin</surname><given-names>M</given-names></name>
<name><surname>Bj&#246;rck</surname><given-names>L</given-names></name>
<name><surname>Tapper</surname><given-names>H</given-names></name>
</person-group>
<year>2006</year>
<article-title>Streptococcus pyogenes bacteria modulate membrane traffic in human neutrophils and selectively inhibit azurophilic granule fusion with phagosomes</article-title>
<source>Cell Microbiol</source>
<volume>8</volume>
<fpage>690</fpage>
<lpage>703</lpage>
<pub-id pub-id-type="doi">10.1111/j.1462-5822.2005.00662.x</pub-id>
<pub-id pub-id-type="pmid">16548894</pub-id>
<pub-id pub-id-type="other">https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&#38;scp=33644870686&#38;origin=inward</pub-id>
</element-citation>
</ref>
<ref id="ref33">
<label>33</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Belaaouaj</surname><given-names>A</given-names></name>
<name><surname>McCarthy</surname><given-names>R</given-names></name>
<name><surname>Baumann</surname><given-names>M</given-names></name>
<name><surname>Gao</surname><given-names>Z</given-names></name>
<name><surname>Ley</surname><given-names>TJ</given-names></name>
<name><surname>Abraham</surname><given-names>SN</given-names></name>
<name><surname>Shapiro</surname><given-names>SD</given-names></name>
</person-group>
<year>1998</year>
<article-title>Mice lacking neutrophil elastase reveal impaired host defense against gram negative bacterial sepsis</article-title>
<source>Nat Med</source>
<volume>4</volume>
<fpage>615</fpage>
<lpage>618</lpage>
<pub-id pub-id-type="doi">10.1038/nm0598-615</pub-id>
<pub-id pub-id-type="pmid">9585238</pub-id>
<pub-id pub-id-type="other">https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&#38;scp=0031836105&#38;origin=inward</pub-id>
</element-citation>
</ref>
<ref id="ref34">
<label>34</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Garcia</surname><given-names>R</given-names></name>
<name><surname>Gusmani</surname><given-names>L</given-names></name>
<name><surname>Murgia</surname><given-names>R</given-names></name>
<name><surname>Guarnaccia</surname><given-names>C</given-names></name>
<name><surname>Cinco</surname><given-names>M</given-names></name>
<name><surname>Rottini</surname><given-names>G</given-names></name>
</person-group>
<year>1998</year>
<article-title>Elastase is the only human neutrophil granule protein that alone is responsible for in vitro killing of Borrelia burgdorferi</article-title>
<source>Infect Immun</source>
<volume>66</volume>
<fpage>1408</fpage>
<lpage>1412</lpage>
<pub-id pub-id-type="doi">10.1128/IAI.66.4.1408-1412.1998</pub-id>
<pub-id pub-id-type="pmid">9529060</pub-id>
<pub-id pub-id-type="pmcid">PMC108067</pub-id>
<pub-id pub-id-type="other">https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&#38;scp=0032038653&#38;origin=inward</pub-id>
</element-citation>
</ref>
<ref id="ref35">
<label>35</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Tkalcevic</surname><given-names>J</given-names></name>
<name><surname>Novelli</surname><given-names>M</given-names></name>
<name><surname>Phylactides</surname><given-names>M</given-names></name>
<name><surname>Iredale</surname><given-names>JP</given-names></name>
<name><surname>Segal</surname><given-names>AW</given-names></name>
<name><surname>Roes</surname><given-names>J</given-names></name>
</person-group>
<year>2000</year>
<article-title>Impaired immunity and enhanced resistance to endotoxin in the absence of neutrophil elastase and cathepsin G</article-title>
<source>Immunity</source>
<volume>12</volume>
<fpage>201</fpage>
<lpage>210</lpage>
<pub-id pub-id-type="doi">10.1016/S1074-7613(00)80173-9</pub-id>
<pub-id pub-id-type="pmid">10714686</pub-id>
<pub-id pub-id-type="other">https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&#38;scp=0034144636&#38;origin=inward</pub-id>
</element-citation>
</ref>
<ref id="ref36">
<label>36</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Reeves</surname><given-names>EP</given-names></name>
<name><surname>Lu</surname><given-names>H</given-names></name>
<name><surname>Jacobs</surname><given-names>HL</given-names></name>
<name><surname>Messina</surname><given-names>CG</given-names></name>
<name><surname>Bolsover</surname><given-names>S</given-names></name>
<name><surname>Gabella</surname><given-names>G</given-names></name>
<name><surname>Potma</surname><given-names>EO</given-names></name>
<name><surname>Warley</surname><given-names>A</given-names></name>
<name><surname>Roes</surname><given-names>J</given-names></name>
<name><surname>Segal</surname><given-names>AW</given-names></name>
</person-group>
<year>2002</year>
<article-title>Killing activity of neutrophils is mediated through activation of proteases by K<sup>+</sup> flux</article-title>
<source>Nature</source>
<volume>416</volume>
<fpage>291</fpage>
<lpage>297</lpage>
<pub-id pub-id-type="doi">10.1038/416291a</pub-id>
<pub-id pub-id-type="pmid">11907569</pub-id>
<pub-id pub-id-type="other">https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&#38;scp=0037149510&#38;origin=inward</pub-id>
</element-citation>
</ref>
<ref id="ref37">
<label>37</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Blander</surname><given-names>JM</given-names></name>
<name><surname>Medzhitov</surname><given-names>R</given-names></name>
</person-group>
<year>2004</year>
<article-title>Regulation of phagosome maturation by signals from toll-like receptors</article-title>
<source>Science</source>
<volume>304</volume>
<fpage>1014</fpage>
<lpage>1018</lpage>
<pub-id pub-id-type="doi">10.1126/science.1096158</pub-id>
<pub-id pub-id-type="pmid">15143282</pub-id>
<pub-id pub-id-type="other">https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&#38;scp=2342525996&#38;origin=inward</pub-id>
</element-citation>
</ref>
<ref id="ref38">
<label>38</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Cavalli</surname><given-names>V</given-names></name>
<name><surname>Vilbois</surname><given-names>F</given-names></name>
<name><surname>Corti</surname><given-names>M</given-names></name>
<name><surname>Marcote</surname><given-names>MJ</given-names></name>
<name><surname>Tamura</surname><given-names>K</given-names></name>
<name><surname>Karin</surname><given-names>M</given-names></name>
<name><surname>Arkinstall</surname><given-names>S</given-names></name>
<name><surname>Gruenberg</surname><given-names>J</given-names></name>
</person-group>
<year>2001</year>
<article-title>The stress-induced MAP kinase p38 regulates endocytic trafficking via the GDI:Rab5 complex</article-title>
<source>Mol Cell</source>
<volume>7</volume>
<fpage>421</fpage>
<lpage>432</lpage>
<pub-id pub-id-type="doi">10.1016/S1097-2765(01)00189-7</pub-id>
<pub-id pub-id-type="pmid">11239470</pub-id>
<pub-id pub-id-type="other">https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&#38;scp=0035105295&#38;origin=inward</pub-id>
</element-citation>
</ref>
<ref id="ref39">
<label>39</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Ward</surname><given-names>RA</given-names></name>
<name><surname>Nakamura</surname><given-names>M</given-names></name>
<name><surname>McLeish</surname><given-names>KR</given-names></name>
</person-group>
<year>2000</year>
<article-title>Priming of the neutrophil respiratory burst involves p38 mitogen-activated protein kinase-dependent exocytosis of flavocytochrome b558-containing granules</article-title>
<source>J Biol Chem</source>
<volume>275</volume>
<fpage>36713</fpage>
<lpage>36719</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M003017200</pub-id>
<pub-id pub-id-type="pmid">10976103</pub-id>
<pub-id pub-id-type="other">https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&#38;scp=0034711296&#38;origin=inward</pub-id>
</element-citation>
</ref>
<ref id="ref40">
<label>40</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Schnyder</surname><given-names>B</given-names></name>
<name><surname>Meunier</surname><given-names>PC</given-names></name>
<name><surname>Car</surname><given-names>BD</given-names></name>
</person-group>
<year>1998</year>
<article-title>Inhibition of kinases impairs neutrophil activation and killing of Staphylococcus aureus</article-title>
<source>Biochem J</source>
<volume>331</volume>
<issue>Pt 2</issue>
<fpage>489</fpage>
<lpage>495</lpage>
<pub-id pub-id-type="doi">10.1042/bj3310489</pub-id>
<pub-id pub-id-type="pmid">9531489</pub-id>
<pub-id pub-id-type="pmcid">PMC1219380</pub-id>
<pub-id pub-id-type="other">https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&#38;scp=0032522553&#38;origin=inward</pub-id>
</element-citation>
</ref>
<ref id="ref41">
<label>41</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Zhong</surname><given-names>B</given-names></name>
<name><surname>Jiang</surname><given-names>K</given-names></name>
<name><surname>Gilvary</surname><given-names>DL</given-names></name>
<name><surname>Epling-Burnette</surname><given-names>PK</given-names></name>
<name><surname>Ritchey</surname><given-names>C</given-names></name>
<name><surname>Liu</surname><given-names>J</given-names></name>
<name><surname>Jackson</surname><given-names>RJ</given-names></name>
<name><surname>Hong-Geller</surname><given-names>E</given-names></name>
<name><surname>Wei</surname><given-names>S</given-names></name>
</person-group>
<year>2003</year>
<article-title>Human neutrophils utilize a Rac/Cdc42-dependent MAPK pathway to direct intracellular granule mobilization toward ingested microbial pathogens</article-title>
<source>Blood</source>
<volume>101</volume>
<fpage>3240</fpage>
<lpage>3248</lpage>
<pub-id pub-id-type="doi">10.1182/blood-2001-12-0180</pub-id>
<pub-id pub-id-type="pmid">12511425</pub-id>
<pub-id pub-id-type="other">https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&#38;scp=0038281350&#38;origin=inward</pub-id>
</element-citation>
</ref>
<ref id="ref42">
<label>42</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Murphy</surname><given-names>R</given-names></name>
<name><surname>DeCoursey</surname><given-names>TE</given-names></name>
</person-group>
<year>2006</year>
<article-title>Charge compensation during the phagocyte respiratory burst</article-title>
<source>Biochim Biophys Acta</source>
<volume>1757</volume>
<fpage>996</fpage>
<lpage>1011</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbabio.2006.01.005</pub-id>
<pub-id pub-id-type="pmid">16483534</pub-id>
<pub-id pub-id-type="other">https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&#38;scp=33748894518&#38;origin=inward</pub-id>
</element-citation>
</ref>
<ref id="ref43">
<label>43</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Gold</surname><given-names>SB</given-names></name>
<name><surname>Hanes</surname><given-names>DM</given-names></name>
<name><surname>Stites</surname><given-names>DP</given-names></name>
<name><surname>Fudenberg</surname><given-names>HH</given-names></name>
</person-group>
<year>1974</year>
<article-title>Abnormal kinetics of degranulation in chronic granulomatous disease</article-title>
<source>N Engl J Med</source>
<volume>291</volume>
<fpage>332</fpage>
<lpage>337</lpage>
<pub-id pub-id-type="doi">10.1056/NEJM197408152910704</pub-id>
<pub-id pub-id-type="pmid">4850362</pub-id>
<pub-id pub-id-type="other">https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&#38;scp=0016269090&#38;origin=inward</pub-id>
</element-citation>
</ref>
<ref id="ref44">
<label>44</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Ellis</surname><given-names>JA</given-names></name>
<name><surname>Mayer</surname><given-names>SJ</given-names></name>
<name><surname>Jones</surname><given-names>OT</given-names></name>
</person-group>
<year>1988</year>
<article-title>The effect of the NADPH oxidase inhibitor diphenyleneiodonium on aerobic and anaerobic microbicidal activities of human neutrophils</article-title>
<source>Biochem J</source>
<volume>251</volume>
<fpage>887</fpage>
<lpage>891</lpage>
<pub-id pub-id-type="doi">10.1042/bj2510887</pub-id>
<pub-id pub-id-type="pmid">2843166</pub-id>
<pub-id pub-id-type="pmcid">PMC1149085</pub-id>
<pub-id pub-id-type="other">https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&#38;scp=0023894234&#38;origin=inward</pub-id>
</element-citation>
</ref>
<ref id="ref45">
<label>45</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Segal</surname><given-names>AW</given-names></name>
<name><surname>Geisow</surname><given-names>M</given-names></name>
<name><surname>Garcia</surname><given-names>R</given-names></name>
<name><surname>Harper</surname><given-names>A</given-names></name>
<name><surname>Miller</surname><given-names>R</given-names></name>
</person-group>
<year>1981</year>
<article-title>The respiratory burst of phagocytic cells is associated with a rise in vacuolar pH</article-title>
<source>Nature</source>
<volume>290</volume>
<fpage>406</fpage>
<lpage>409</lpage>
<pub-id pub-id-type="doi">10.1038/290406a0</pub-id>
<pub-id pub-id-type="pmid">7219526</pub-id>
<pub-id pub-id-type="other">https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&#38;scp=0019480640&#38;origin=inward</pub-id>
</element-citation>
</ref>
<ref id="ref46">
<label>46</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Weiss</surname><given-names>J</given-names></name>
<name><surname>Kao</surname><given-names>L</given-names></name>
<name><surname>Victor</surname><given-names>M</given-names></name>
<name><surname>Elsbach</surname><given-names>P</given-names></name>
</person-group>
<year>1987</year>
<article-title>Respiratory burst facilitates the digestion of Escherichia coli killed by polymorphonuclear leukocytes</article-title>
<source>Infect Immun</source>
<volume>55</volume>
<fpage>2142</fpage>
<lpage>2147</lpage>
<pub-id pub-id-type="doi">10.1128/iai.55.9.2142-2147.1987</pub-id>
<pub-id pub-id-type="pmid">3305366</pub-id>
<pub-id pub-id-type="pmcid">PMC260670</pub-id>
</element-citation>
</ref>
<ref id="ref47">
<label>47</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Nauseef</surname><given-names>WM</given-names></name>
</person-group>
<year>2007</year>
<article-title>How human neutrophils kill and degrade microbes: an integrated view</article-title>
<source>Immunol Rev</source>
<volume>219</volume>
<fpage>88</fpage>
<lpage>102</lpage>
<pub-id pub-id-type="doi">10.1111/j.1600-065X.2007.00550.x</pub-id>
<pub-id pub-id-type="pmid">17850484</pub-id>
<pub-id pub-id-type="other">https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&#38;scp=34548588559&#38;origin=inward</pub-id>
</element-citation>
</ref>
<ref id="ref48">
<label>48</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Baran</surname><given-names>H</given-names></name>
<name><surname>Gramer</surname><given-names>M</given-names></name>
<name><surname>L&#246;scher</surname><given-names>W</given-names></name>
</person-group>
<year>1995</year>
<article-title>Alterations in plasma and brain amino acids after administration of the glycine/NMDA receptor partial agonist, D-cycloserine, to mice and rats</article-title>
<source>Eur J Pharmacol</source>
<volume>273</volume>
<fpage>197</fpage>
<lpage>201</lpage>
<pub-id pub-id-type="doi">10.1016/0014-2999(94)00745-S</pub-id>
<pub-id pub-id-type="pmid">7737315</pub-id>
<pub-id pub-id-type="other">https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&#38;scp=0028897366&#38;origin=inward</pub-id>
</element-citation>
</ref>
<ref id="ref49">
<label>49</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Askanazi</surname><given-names>J</given-names></name>
<name><surname>Elwyn</surname><given-names>DH</given-names></name>
<name><surname>Kinney</surname><given-names>JM</given-names></name>
<name><surname>Gump</surname><given-names>FE</given-names></name>
<name><surname>Michelsen</surname><given-names>CB</given-names></name>
<name><surname>Stinchfield</surname><given-names>FE</given-names></name>
<name><surname>F&#252;rst</surname><given-names>P</given-names></name>
<name><surname>Vinnars</surname><given-names>E</given-names></name>
<name><surname>Bergstr&#246;m</surname><given-names>J</given-names></name>
</person-group>
<year>1978</year>
<article-title>Muscle and plasma amino acids after injury: the role of inactivity</article-title>
<source>Ann Surg</source>
<volume>188</volume>
<fpage>797</fpage>
<lpage>803</lpage>
<pub-id pub-id-type="doi">10.1097/00000658-197812000-00014</pub-id>
<pub-id pub-id-type="pmid">736657</pub-id>
<pub-id pub-id-type="pmcid">PMC1397017</pub-id>
<pub-id pub-id-type="other">https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&#38;scp=0018106149&#38;origin=inward</pub-id>
</element-citation>
</ref>
</ref-list>
<sec sec-type="display-objects">
<title>Figures</title>
<fig id="F1" position="float">
<label>Fig. 1</label>
<caption>
<title>Glycine increases neutrophil bactericidal activity via enhanced intracellular reactive oxygen species (ROS) production.</title>
<p>(A) Glycine concentration-dependently increases neutrophil bactericidal activity. Various concentrations of glycine were added to HBSS. Strychnine blocked glycine-induced enhancement of neutrophil bactericidal activity. The average of three experiments is shown (mean &#177; SE). (B) Glycine increases the clearance of intraperitoneally injected <italic>E. coli</italic> in mice. Mice were pretreated subcutaneously with PBS or strychnine (0.4 mg/kg) 30 min before an i.p. injection of <italic>E. coli</italic> (5 &#215; 10<sup>8</sup>). At 30 min after <italic>E. coli</italic> injection, vehicle (PBS) or glycine (30 mg/kg) was subcutaneously injected. Eight hours after <italic>E. coli</italic> injection, mice were killed and the number of CFUs in peritoneal lavage fluid was counted. n = 9&#8722;10 per group. *p &#60; 0.05; **p &#60; 0.01; ***p &#60; 0.001 by Student&#8217;s t-test. (C) Effect of DPI on glycine-induced enhancement of bactericidal activity. Neutrophils were pretreated with DPI (1 &#956;M) for 1 h before glycine (500 &#956;M) treatment in HBSS medium. (D) Effects of glycine on ROS generation in neutrophils. Neutrophils were exposed to <italic>E. coli</italic> for 20 min. Unphagocytosed <italic>E. coli</italic> was washed away and neutrophils were further incubated with or without glycine (500 &#956;M) for 15 min. ROS production in neutrophils was measured with DCF-DA. (E) GIyR-ROS-Ca<sup>2+</sup> signaling pathway. (<italic>Left</italic>) Effect of glycine on [Ca<sup>2+</sup>]<sub>i</sub> in neutrophils exposed to <italic>E. coli</italic>. Neutrophils were exposed to <italic>E. coli</italic> for 20 min, and further incubated with or without glycine (1 mM). (<italic>Right</italic>) Neutrophils were pretreated with DPI (1 &#956;M) for 15 min before <italic>E. coli</italic> exposure. CFUs, colony forming units; DPI, diphenylene iodonium; DCF-DA, 2&#8217;,7&#8217;-dichlorodihydrofluorescein diacetate; Gly, glycine; GlyR, glycine receptor.</p>
</caption>
<graphic xlink:href="kjpp-26-4-229-f1.tif"/>
</fig>
<fig id="F2" position="float">
<label>Fig. 2</label>
<caption>
<title>Glycine induces <sup>36</sup>CI<sup>&#8211;</sup> uptake and [Ca<sup>2+</sup>]<sub>i</sub> increase in neutrophils pretreated with phorbol myristate acetate (PMA).</title>
<p>(A) <sup>36</sup>CI<sup>&#8211;</sup> influx in response to glycine (1 mM) in neutrophils. Neutrophils were incubated with 2 &#956;g/ml PMA for 20 min. Uptake was initiated by adding <sup>36</sup>CI<sup>&#8211;</sup> solution and influx was terminated by the addition of 4 ml of ice-cold HEPES butter and rapid filtration. Neutrophils were placed in scintillation vials and solubilized with 0.2 N NaOH for 2 h. EcoLume was added and radioactivity was measured with a Beckman LS-5801 liquid scintillator. (B) Neutrophils were pretreated with 2 &#956;g/ml PMA for 20 min, and glycine (500 &#956;M)-induced reactive oxygen species (ROS) generation was measured. (C) Effect of glycine (1 mM) on [Ca<sup>2+</sup>]<sub>i</sub> in vehicle- or PMA-pretreated neutrophils. Neutrophils were pretreated with diphenylene iodonium (DPI) (1 &#956;M) for 15 min before PMA exposure. (A&#8211;C) The average of three experiments is shown (mean &#177; SE). *p &#60; 0.05; **p &#60; 0.01;***p &#60; 0.001 by Student&#8217;s t-test. DCF-DA, 2&#8217;,7&#8217;-dichlorodihydrofluorescein diacetate.</p>
</caption>
<graphic xlink:href="kjpp-26-4-229-f2.tif"/>
</fig>
<fig id="F3" position="float">
<label>Fig. 3</label>
<caption>
<title>Effects of TRPM2-specific shRNA on glycine (1 mM)-induced increase in [Ca<sup>2+</sup>]<sub>i</sub> in neutrophils (A), and on glycine (500&#956;M)-induced enhancement of bactericidal activity (B).</title>
<p>Neutrophils were transfected with shRNA against TRPM2. After 24 h, the effects of glycine on [Ca<sup>2+</sup>]<sub>i.</sub> in neutrophils (A) and bactericidal activity (B) were assayed. The average of three experiments is shown (mean &#177; SE). *p &#60; 0.05 by Student&#8217;s t-test.</p>
</caption>
<graphic xlink:href="kjpp-26-4-229-f3.tif"/>
</fig>
<fig id="F4" position="float">
<label>Fig. 4</label>
<caption>
<title>Subcellular localization of glycine receptor (GlyR)&#945;2 in human neutrophils.</title>
<p>(A) Isolated neutrophils were pressurized with N<sub>2</sub> gas for 20 min at 350 psi, and cavitated neutrophils were loaded onto three separate Percoll density gradients. After centrifugation, four distinct bands were observed from the bottom, designated as &#945;-band (azurophil granules), &#946;<sub>1</sub>-band (specific granules), &#946;<sub>2</sub>-band (tertiary granules), and &#947;-band (secretory vesicles and plasma membranes). For negative controls, non-transfected HEK 293 cells were used. For positive controls, neutrophils and GlyR&#945;2-transfected HEK 293 cells (HEK+&#945;2) were used. Western blot revealed the localization of GlyR&#945;2 in the &#947;-band (secretory vesicles and plasma membranes), with or without blocking peptide against GlyR&#945;2. Exposure of neutrophils to <italic>E. coli</italic> or phorbol myristate acetate (PMA) effectively translocated GlyR to the plasma membrane. Representative fluorescein isothiocyanate (FITC) histograms on membrane expression of GlyR&#945;2 in response to <italic>E. coli</italic> (B) or PMA (C). Neutrophils were treated with <italic>E. coli</italic> or PMA for 5 min. After fixation, neutrophils were stained with FITC-conjugated anti-GlyR&#945;2 antibody for 30 min. (D) A representative FACS histogram on membrane expression of flavocytochrome b588 in response to <italic>E.</italic> <italic>coli.</italic> Neutrophils were exposed to <italic>E. coli</italic> for 20 min.</p>
</caption>
<graphic xlink:href="kjpp-26-4-229-f4.tif"/>
</fig>
<fig id="F5" position="float">
<label>Fig. 5</label>
<caption>
<title>Glycine enhances azurophil granule-phagosome fusion via p38 mitogen-activated protein kinase (MAPK).</title>
<p>(A) Effects of strychnine, diphenylene iodonium (DPI) and SB203580 on glycine-induced enhancement of fluid-phase pinocytosis. Uptake of Lucifer yellow in neutrophils was measured as fluid-phase pinocytosis. Neutrophils were exposed to <italic>E. coli</italic> for 20 min. Unphagocytosed <italic>E. coli</italic> was washed away and neutrophils were further incubated with glycine (500 &#956;M) for 15 min in the presence of 0.5 mg/ml Lucifer yellow. Strychnine (1 &#956;M), DPI (1 &#956;M) or SB203580 (10 &#956;M) was added during 15 min of incubation. Neutrophils were lysed with ice-cold distilled water for 1 h and fluorescence was measured. (B) Effects of strychnine, DPI, and SB203580 on zymosan-CD63 fusion. Neutrophils were allowed to ingest Texas Red-conjugated zymosan for 20 min. Unphagocytosed zymosan particles were washed away and neutrophils were further incubated with glycine in the presence of strychnine, DPI, or SB203580. Neutrophils were fixed and stained with anti-CD63 antibody. Stacks of 12&#8211;16 confocal images were collected with an LSM 510 laser-scanning confocal microscope (Carl Zeiss, Jena, Germany) and analyzed by LSM Image Examiner software (Carl Zeiss). The fusion of CD63 and zymosan particles was analyzed by measuring the area of co-localization between CD63 and zymosan particles, which was divided by total intracellular zymosan area in confocal images of neutrophils at each slice of 0.52 &#956;m in thickness. (C) Effects of protease inhibitor cocktail and SB203580 on glycine-induced enhancement of bactericidal activity. Neutrophils were pretreated with a protease inhibitor cocktail or SB203580 for 1 h before <italic>E. coli</italic> exposure. (A&#8211;C) The average of three experiments is shown (mean &#177; SE). ***p &#60; 0.001 by Student&#8217;s t-test.</p>
</caption>
<graphic xlink:href="kjpp-26-4-229-f5.tif"/>
</fig>
<fig id="F6" position="float">
<label>Fig. 6</label>
<caption>
<title>Model of GlyR&#945;2-mediated enhancement of neutrophil bactericidal activity.</title>
<p>GlyR, glycine receptor; MAPK, mitogen-activated protein kinase; ROS, reactive oxygen species.</p>
</caption>
<graphic xlink:href="kjpp-26-4-229-f6.tif"/>
</fig>
</sec>
</back>
</article>